NO971517D0 - Peptider og farmasöytiske sammensetninger omfattende dem - Google Patents
Peptider og farmasöytiske sammensetninger omfattende demInfo
- Publication number
- NO971517D0 NO971517D0 NO971517A NO971517A NO971517D0 NO 971517 D0 NO971517 D0 NO 971517D0 NO 971517 A NO971517 A NO 971517A NO 971517 A NO971517 A NO 971517A NO 971517 D0 NO971517 D0 NO 971517D0
- Authority
- NO
- Norway
- Prior art keywords
- cells
- peptides
- pharmaceutical compositions
- idiotypic
- activity
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11119694A IL111196A0 (en) | 1994-10-07 | 1994-10-07 | Peptides and pharmaceutical compositions comprising them |
| PCT/US1995/012686 WO1996011214A1 (en) | 1994-10-07 | 1995-10-10 | Peptides and pharmaceutical compositions comprising them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971517D0 true NO971517D0 (no) | 1997-04-03 |
| NO971517L NO971517L (no) | 1997-05-22 |
Family
ID=11066614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971517A NO971517L (no) | 1994-10-07 | 1997-04-03 | Peptider og farmasöytiske sammensetninger omfattende dem |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0783524B1 (no) |
| JP (1) | JPH10507345A (no) |
| KR (1) | KR100381711B1 (no) |
| AT (1) | ATE289611T1 (no) |
| AU (1) | AU708301B2 (no) |
| CA (1) | CA2201935A1 (no) |
| CZ (1) | CZ103197A3 (no) |
| DE (1) | DE69534024T2 (no) |
| FI (1) | FI971427A (no) |
| HU (1) | HUT77484A (no) |
| IL (1) | IL111196A0 (no) |
| NO (1) | NO971517L (no) |
| PL (1) | PL319831A1 (no) |
| SK (1) | SK44197A3 (no) |
| WO (1) | WO1996011214A1 (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716963B1 (en) | 1998-05-22 | 2004-04-06 | Abbott Laboratories | Peptide antiangiogenic drugs |
| US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
| JP3820105B2 (ja) | 1998-10-23 | 2006-09-13 | キリン−アムジエン・インコーポレーテツド | Ｍｐ１受容体に結合し血小板生成活性を有する二量体トロンボポエチンペプチド模倣体 |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| EP1773400A2 (en) | 2004-07-08 | 2007-04-18 | Amgen Inc. | Therapeutic peptides |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| WO2015145449A2 (en) * | 2014-03-27 | 2015-10-01 | Yeda Research And Development Co. Ltd. | T-cell receptor cdr3 peptides and antibodies |
| KR20230155600A (ko) | 2014-04-03 | 2023-11-10 | 아이쥐엠 바이오사이언스 인코포레이티드 | 변형된 j-사슬 |
| AU2016329197B2 (en) | 2015-09-30 | 2021-01-21 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
| WO2017059387A1 (en) | 2015-09-30 | 2017-04-06 | Igm Biosciences, Inc. | Binding molecules with modified j-chain |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4886743A (en) * | 1985-04-24 | 1989-12-12 | California Institute Of Technology | Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof |
-
1994
- 1994-10-07 IL IL11119694A patent/IL111196A0/xx unknown
-
1995
- 1995-10-10 CZ CZ971031A patent/CZ103197A3/cs unknown
- 1995-10-10 HU HU9800152A patent/HUT77484A/hu unknown
- 1995-10-10 AT AT95937323T patent/ATE289611T1/de active IP Right Revival
- 1995-10-10 DE DE69534024T patent/DE69534024T2/de not_active Expired - Lifetime
- 1995-10-10 WO PCT/US1995/012686 patent/WO1996011214A1/en active IP Right Grant
- 1995-10-10 KR KR1019970702283A patent/KR100381711B1/ko not_active IP Right Cessation
- 1995-10-10 PL PL95319831A patent/PL319831A1/xx unknown
- 1995-10-10 SK SK441-97A patent/SK44197A3/sk unknown
- 1995-10-10 AU AU39462/95A patent/AU708301B2/en not_active Ceased
- 1995-10-10 CA CA002201935A patent/CA2201935A1/en not_active Abandoned
- 1995-10-10 JP JP8512640A patent/JPH10507345A/ja active Pending
- 1995-10-10 EP EP95937323A patent/EP0783524B1/en not_active Expired - Lifetime
-
1997
- 1997-04-03 NO NO971517A patent/NO971517L/no not_active Application Discontinuation
- 1997-04-04 FI FI971427A patent/FI971427A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0783524A1 (en) | 1997-07-16 |
| IL111196A0 (en) | 1994-12-29 |
| WO1996011214A1 (en) | 1996-04-18 |
| EP0783524B1 (en) | 2005-02-23 |
| NO971517L (no) | 1997-05-22 |
| HUT77484A (hu) | 1998-05-28 |
| FI971427A (fi) | 1997-05-26 |
| CA2201935A1 (en) | 1996-04-18 |
| DE69534024D1 (de) | 2005-03-31 |
| KR100381711B1 (ko) | 2003-07-16 |
| CZ103197A3 (en) | 1997-09-17 |
| ATE289611T1 (de) | 2005-03-15 |
| KR970706306A (ko) | 1997-11-03 |
| FI971427A0 (fi) | 1997-04-04 |
| AU708301B2 (en) | 1999-07-29 |
| AU3946295A (en) | 1996-05-02 |
| PL319831A1 (en) | 1997-09-01 |
| SK44197A3 (en) | 1997-11-05 |
| EP0783524A4 (en) | 2000-05-17 |
| DE69534024T2 (de) | 2006-01-12 |
| JPH10507345A (ja) | 1998-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9710452A (pt) | Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos | |
| CA2219988A1 (en) | Cd16-ii variants | |
| NO930011D0 (no) | Tilfeldig boi-oligomer bibilotek og fremgangsmaate for syntese og anvendelse derav | |
| EP0671920A4 (en) | AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES. | |
| DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| NO971517D0 (no) | Peptider og farmasöytiske sammensetninger omfattende dem | |
| IS1966B (is) | Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki | |
| HUP9901688A2 (hu) | A diabétesz kezelésére szolgáló, humán hősokk protein 60-ból származó új peptidek, készítmények, eljárások és kitek | |
| HUP0102479A2 (hu) | Neisseria meningitidis-ből származó BASBO29-polinukleotid(ok) és polipeptidek | |
| NO952385D0 (no) | Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen | |
| HUP0100048A2 (hu) | Arilszubsztituált piperazinszármazékok, alkalmazásuk gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
| DE69738600D1 (de) | Neuroaktive peptide | |
| DE69326145D1 (de) | Synthetische peptide für die behandlung von myasthenia gravis | |
| DK0722460T3 (da) | Peptidderivater der er terapeutisk aktive i blodkoaguleringskaskaden, fremgangsmåde til fremstilling heraf og farmaceutiske | |
| DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
| DE69832075D1 (de) | Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks | |
| NO900255L (no) | Peptider med t-cellehjelperaktivitet. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |